Veröffentlichungen

Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group

D.A. Eichenauer
A. Plütschow
S. Kreissl
M. Sökler
J.C. Hellmuth
J. Meissner
S. Mathas
M.S. Topp
K. Behringer
W. Klapper
G. Kuhnert
M. Dietlein
C. Kobe
M. Fuchs
V. Diehl
A. Engert
P. Borchmann

SIRT1 regulates macrophage self-renewal

F. Imperatore
J. Maurizio
S. Vargas Aguilar
C.J. Busch
J. Favret
E. Kowenz-Leutz
W. Cathou
R. Gentek
P. Perrin
A. Leutz
C. Berruyer
M.H. Sieweke

09. Mai 2017 in Transl Psychiatr

Maternal immune activation results in complex microglial transcriptome signature in the adult offspring that is reversed by minocycline treatment

D. Mattei
A. Ivanov
C. Ferrai
P. Jordan
D. Guneykaya
A. Buonfiglioli
W. Schaafsma
P. Przanowski
W. Deuther-Conrad
P. Brust
S. Hesse
M. Patt
O. Sabri
T.L. Ross
B.J.L. Eggen
E.W.G.M. Boddeke
B. Kaminska
D. Beule
A. Pombo
H. Kettenmann
S.A. Wolf

Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma

K.D. Wurster
F. Hummel
J. Richter
M. Giefing
S. Hartmann
M.L. Hansmann
S. Kreher
K. Köchert
D. Krappmann
W. Klapper
M. Hummel
S.S. Wenzel
G. Lenz
M. Janz
B. Dörken
R. Siebert
S. Mathas

C/EBP-induced transdifferentiation reveals granulocyte-macrophage precursor-like plasticity of B cells

B. Cirovic
J. Schönheit
E. Kowenz-Leutz
J. Ivanovska
C. Klement
N. Pronina
V. Bégay
A. Leutz

Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin's lymphoma

J. Du
M. Neuenschwander
Y. Yu
J.H.M. Däbritz
N.R. Neuendorff
K. Schleich
A. Bittner
M. Milanovic
G. Beuster
S. Radetzki
E. Specker
M. Reimann
F. Rosenbauer
S. Mathas
P. Lohneis
M. Hummel
B. Dörken
J.P. von Kries
S. Lee
C.A. Schmitt

BAY 43-9006/Sorafenib blocks CSF1R activity and induces apoptosis in various classical Hodgkin lymphoma cell lines

K. Ullrich
K.D. Wurster
B. Lamprecht
K. Koechert
A. Engert
B. Doerken
M. Janz
S. Mathas

Genomic loss of the putative tumor suppressor gene E2A in human lymphoma

A. Steininger
M. Moebs
R. Ullmann
K. Koechert
S. Kreher
B. Lamprecht
I. Anagnostopoulos
M. Hummel
J. Richter
M. Beyer
M. Janz
C.D. Klemke
H. Stein
B. Doerken
W. Sterry
E. Schrock
S. Mathas
C. Assaf

Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells

U.M. Fagerli
K. Ullrich
T. Stuehmer
T. Holien
K. Koechert
R.U. Holt
O. Bruland
M. Chatterjee
H. Nogai
G. Lenz
J.D. Shaughnessy
S. Mathas
A. Sundan
R.C. Bargou
B. Doerken
M. Borset
M. Janz

High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas

K. Koechert
K. Ullrich
S. Kreher
J.C. Aster
M. Kitagawa
K. Joehrens
I. Anagnostopoulos
F. Jundt
B. Lamprecht
U. Zimber-Strobl
H. Stein
M. Janz
B. Doerken
S. Mathas